International journal of women's health · 2026
Impact of Short-Term Estrogen Therapy on Endometrial Polyps Recurrence in Women with Intrauterine Adhesion and Endometrial Polyps: A Retrospective Cohort Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jiang Sushi, Yi Xinyu, Zheng Miaoxian, Ouyang Yanlan, Chen Yaxiao, Xie Meiqing, Chen Shengfu, Chen Dongmei, Zhong Xiaozhu
Аннотация
OBJECTIVE: To investigate whether short-term postoperative estrogen-related therapy is associated with recurrence of intrauterine adhesions (IUA), endometrial polyps (EPs), and pregnancy outcomes in women with concomitant IUA and EPs.
METHODS: This single-center retrospective cohort study included women (18-45 years) diagnosed with both IUA and EPs who underwent concurrent hysteroscopic transcervical resection of adhesions (TCRA) and polypectomy from January 2019 to June 2024. Patients were grouped by postoperative regimen: (1) estradiol-dydrogesterone sequential therapy (Femoston; estradiol 2 mg/dydrogesterone 10 mg; 2-3 months), (2) combined oral contraceptive (Yaz; ethinylestradiol 0.02 mg/drospirenone 3 mg; 3 months), or (3) no hormonal therapy. Recurrence was confirmed by transvaginal ultrasound and/or hysteroscopy.
RESULTS: A total of 166 women were included (sequential therapy, n=47; COC, n=32; no hormone, n=87). Baseline polyp multiplicity differed among groups (P=0.003), with a higher proportion of multiple EPs in the COC group. Postoperative IUD/balloon placement also differed among groups (P=0.012). Overall recurrence rates were 6.6% for IUA and 4.8% for EPs. No statistically significant differences were observed among groups in postoperative menstrual changes, recurrence rates, time to recurrence, or pregnancy outcomes (all P>0.05). Follow-up duration did not differ significantly among groups.
CONCLUSION: In this retrospective cohort, no statistically significant differences were observed among short-term sequential estrogen-progestin therapy, COC use, and no hormonal therapy with respect to IUA recurrence, EP recurrence, or pregnancy outcomes. Short-term estradiol-dydrogesterone therapy was not associated with increased EP recurrence in women with IUA and a single EP. These findings are observational and should be confirmed in prospective studies.
METHODS: This single-center retrospective cohort study included women (18-45 years) diagnosed with both IUA and EPs who underwent concurrent hysteroscopic transcervical resection of adhesions (TCRA) and polypectomy from January 2019 to June 2024. Patients were grouped by postoperative regimen: (1) estradiol-dydrogesterone sequential therapy (Femoston; estradiol 2 mg/dydrogesterone 10 mg; 2-3 months), (2) combined oral contraceptive (Yaz; ethinylestradiol 0.02 mg/drospirenone 3 mg; 3 months), or (3) no hormonal therapy. Recurrence was confirmed by transvaginal ultrasound and/or hysteroscopy.
RESULTS: A total of 166 women were included (sequential therapy, n=47; COC, n=32; no hormone, n=87). Baseline polyp multiplicity differed among groups (P=0.003), with a higher proportion of multiple EPs in the COC group. Postoperative IUD/balloon placement also differed among groups (P=0.012). Overall recurrence rates were 6.6% for IUA and 4.8% for EPs. No statistically significant differences were observed among groups in postoperative menstrual changes, recurrence rates, time to recurrence, or pregnancy outcomes (all P>0.05). Follow-up duration did not differ significantly among groups.
CONCLUSION: In this retrospective cohort, no statistically significant differences were observed among short-term sequential estrogen-progestin therapy, COC use, and no hormonal therapy with respect to IUA recurrence, EP recurrence, or pregnancy outcomes. Short-term estradiol-dydrogesterone therapy was not associated with increased EP recurrence in women with IUA and a single EP. These findings are observational and should be confirmed in prospective studies.